In 2019, pharmaceutical companies spent $83 billion dollars on research and development. After accounting for inflation, that’s roughly 10 times what the industry spent in the 1980s, according ...

--NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together ...

Pharmaceutical market research analysis (PMRA) can validate a product's potential reach and market penetration capabilities. Investors use it to put a value on drug-making companies and their ...

For the pharmaceutical company, literacy is needed in specialized and core job skills, including research, supply chain, and finance. Then there's fluency in AI technology.

The pharmaceutical industry is vital to human health, but it also has a significant environmental impact. It contributes up to 19% of Australia's health care sector's greenhouse gas (GHG ...

The Shanghai Administration for Market Regulation (AMR) has released a set of illustrative sample cases under the Compliance Guidelines ...

Collegium Pharmaceutical Inc. research and ratings by Barron's. View COLL revenue estimates and earnings estimates, as well as in-depth analyst breakdowns.

American pharmaceutical companies producing in Singapore rather than the U.S. for the Asian market also add to the U.S. bilateral trade deficits in Asia, as US companies are generating exports for ...

The rise of Chinese biotech Until the 1980s, when China opened up its economy, most of its pharmaceutical firms were state-owned. For most of the past 40 years, Chinese biotech companies were ...